Figure 1 from Diagnosis of a Nonpalpable Intraductal Papilloma without Radiological Abnormality by Nipple Discharge Smear Examination: A Case Report, published in Breast Cancer: Basic and Clinical Research http://www.la-press.com/article.php?article_id=4154
Do you love medicine? Check out Figure 1! This app contains real photos from real patients! Great for nursing, pre-Med, pre-PA, radiology, medical student, and more! http://download.figure1.com/summer2016?utm_campaign=jwolfe
Love medicine? Check out Figure 1! Real photos from real patients! Interact and learn from medical professionals all around the world! http://download.figure1.com/summer2016?utm_campaign=jwolfe Nursing, pre-med, pre-PA, radiology, MD, DO, medical, student, doctor, physicians assistant, nurse practitioner
As social media users widen, the radiology department at Cincinnati Children's has taken advantage of using these platforms to educate other medical professionals as well as patients. Dr. Alex Towbin, a radiologist at Cincinnati Children’s, talks about using Figure 1, which is much like Instagram, to reinvent medical education. Cincinnati Children’s is the first in the country to use this system to share information among doctors.
Figure 1 from Dose Distribution in the Heart and Cardiac Chambers Following 4-field Radiation Therapy of Breast Cancer: a Retrospective Study published in Breast Cancer: Basic and Clinical Research http://www.la-press.com/dose-distribution-in-the-heart-and-cardiac-chambers-following-4-field--article-a3602
Rebound on fingolimod let's move away from the hive mind Mult Scler Relat Disord. 2017 Jan;11:1-3. doi: 10.1016/j.msard.2016.11.003. Epub 2016 Nov 11. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis. Gündüz T Kürtüncü M Eraksoy M.Ther Adv Neurol Disord. 2015 Sep;8(5):233-8. doi: 10.1177/1756285615594575. Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment. Faissner S Hoepner R Lukas C Chan A Gold R…
Market Research Globe announces that it has published a new study CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) Detection Devices: Market Shares, Strategy, and Forecasts, Worldwide, 2016 to 2022. The 2016 study has 1,208 pages, 512 tables and figures. Worldwide CBRNE markets are poised to achieve significant growth with the use of detectors that are implemented as platforms, many of them handheld